Literature DB >> 33643486

The Influence of H2-Receptor Antagonist Administration to the 24-h Uptake of I-131 in the Thyroid Gland.

Andreas Lim1,2, Hendra Budiawan2, A Hussein S Kartamihardja1,2.   

Abstract

PURPOSE: The aim of this study was to determine the influence of H2RAs to the 24-h I-131 uptake in the thyroid gland.
MATERIAL AND METHODS: A prospective study with quasi-experimental pre- and post-study design was done. Subjects with normal fT4 level who fulfilled the inclusion criteria were selected. All subjects received 0.2 mCi of I-131 orally, and the thyroid uptake calculations were performed at 24 h later. The same procedure was performed 4 weeks later. All of the subjects were asked to consume H2RAs 1 h before the administration of I-131 of the second procedure. Both 24-h thyroid uptakes were statistically analysed.
RESULTS: A total of 14 subjects were enrolled in this study. Most of them were women (78%) with an average age of 37.6 years old (range: 20-55). This study showed a median of 24-h thyroid uptake of I-131 before and after H2-receptor antagonist of 20.6% (range: 11.1-57.8%) and 16.7% (range: 8.1-39.4%) respectively.
CONCLUSION: H2-receptor antagonist caused a significance reduction of 24-h I-131 uptake value in the thyroid gland. © Korean Society of Nuclear Medicine 2021.

Entities:  

Keywords:  H2-receptor antagonist; Radioactive iodine; Thyroid gland 24-h uptake

Year:  2021        PMID: 33643486      PMCID: PMC7881069          DOI: 10.1007/s13139-020-00676-1

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  13 in total

1.  Historical background of the use of radioactive iodine in medicine.

Authors:  J H MEANS
Journal:  N Engl J Med       Date:  1955-06-02       Impact factor: 91.245

2.  Factors which influence the radioactive iodine thyroidal uptake test.

Authors:  R R GRAYSON
Journal:  Am J Med       Date:  1960-03       Impact factor: 4.965

3.  The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0.

Authors:  Edward B Silberstein; Abass Alavi; Helena R Balon; Susan E M Clarke; Chaitanya Divgi; Michael J Gelfand; Stanley J Goldsmith; Hossein Jadvar; Carol S Marcus; William H Martin; J Anthony Parker; Henry D Royal; Salil D Sarkar; Michael Stabin; Alan D Waxman
Journal:  J Nucl Med       Date:  2012-07-11       Impact factor: 10.057

4.  Procedure guideline for thyroid uptake measurement: 1.0. Society of Nuclear Medicine.

Authors:  D Becker; N D Charkes; H Dworkin; J Hurley; I R McDougall; D Price; H Royal; S Sarkar
Journal:  J Nucl Med       Date:  1996-07       Impact factor: 10.057

5.  Cholinergic-like effects of the new histamine H2-receptor antagonist ranitidine.

Authors:  G Bertaccini; G Coruzzi
Journal:  Agents Actions       Date:  1982-04

Review 6.  Therapeutic radionuclides in nuclear medicine: current and future prospects.

Authors:  Chai-Hong Yeong; Mu-hua Cheng; Kwan-Hoong Ng
Journal:  J Zhejiang Univ Sci B       Date:  2014-10       Impact factor: 3.066

7.  Histamine Receptor 1 and 2 Antagonists Alter Biodistribution of Radioiodine.

Authors:  Oliver Edwards; Ellen D Yakish; Li-Ming Wang; Qi Wu; John M Hoffman; Kathryn A Morton
Journal:  J Nucl Med Technol       Date:  2015-06-25

8.  Effect of histamine H2-receptor blockade on gastric emptying and serum gastrin in man.

Authors:  J A Forrest; R C Heading; J Park; D C Carter; J Lennon; G Lidgard; D J Shearman
Journal:  Scott Med J       Date:  1976-01       Impact factor: 0.729

9.  Effect of ranitidine and cimetidine on gastric emptying of a mixed meal in man.

Authors:  R Corinaldesi; C Scarpignato; A Galassi; V Stanghellini; R Calamelli; G Bertaccini; L Barbara
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-09

Review 10.  Sodium iodide symporter: its role in nuclear medicine.

Authors:  June-Key Chung
Journal:  J Nucl Med       Date:  2002-09       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.